CN Patent

CN102573481A — 脲基苯基取代的三嗪衍生物及其治疗应用

Assigned to Abraxis Bioscience LLC · Expires 2012-07-11 · 14y expired

What this patent protects

一种木质纤维素复合物，其通过在脂肪胺乙氧基化物防掩蔽剂存在下对微粒状木质纤维素材料与聚合MDI的混合物进行压制而制得。

USPTO Abstract

一种木质纤维素复合物，其通过在脂肪胺乙氧基化物防掩蔽剂存在下对微粒状木质纤维素材料与聚合MDI的混合物进行压制而制得。

Drugs covered by this patent

Patent Metadata

Patent number
CN102573481A
Jurisdiction
CN
Classification
—
Expires
2012-07-11
Drug substance claim
No
Drug product claim
No
Assignee
Abraxis Bioscience LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.